These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8408980)

  • 61. Spontaneous hypertensive reactions with monoamine oxidase inhibitors.
    Lavin MR; Mendelowitz A; Kronig MH
    Biol Psychiatry; 1993 Aug; 34(3):146-51. PubMed ID: 8399806
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment with low doses of tranylcypromine resulted in a disappointing remission rate.
    Nolen WA; van den Broek WW; Birkenhäger TK
    Am J Psychiatry; 2007 Mar; 164(3):524; author reply 524. PubMed ID: 17329480
    [No Abstract]   [Full Text] [Related]  

  • 63. Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study.
    Lott M; Greist JH; Jefferson JW; Kobak KA; Katzelnick DJ; Katz RJ; Schaettle SC
    J Clin Psychopharmacol; 1997 Aug; 17(4):255-60. PubMed ID: 9241003
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tranylcypromine plus risperidone for treatment-refractory major depression.
    Stoll AL; Haura G
    J Clin Psychopharmacol; 2000 Aug; 20(4):495-6. PubMed ID: 10917417
    [No Abstract]   [Full Text] [Related]  

  • 65. Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients.
    Hoencamp E; Haffmans PM
    Psychiatry Res; 1991 Mar; 36(3):333-5. PubMed ID: 2062972
    [No Abstract]   [Full Text] [Related]  

  • 66. Severe daytime somnolence in patients treated with an MAOI.
    Teicher MH; Cohen BM; Baldessarini RJ; Cole JO
    Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of initial treatment with antidepressants as a predictor of outcome after 8 weeks.
    Volz HP; Müller H; Sturm Y; Preussler B; Möller HJ
    Psychiatry Res; 1995 Sep; 58(2):107-15. PubMed ID: 8570762
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effects of trazodone on sleep disturbances induced by brofaromine.
    Haffmans PM; Vos MS
    Eur Psychiatry; 1999 Jun; 14(3):167-71. PubMed ID: 10572343
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [High dosage tranylcypromine treatment of "therapy refractory" depressions].
    Schmauss M
    Nervenarzt; 1996 May; 67(5):390-3. PubMed ID: 9005348
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects.
    Bieck PR; Antonin KH
    J Clin Psychopharmacol; 1988 Aug; 8(4):237-45. PubMed ID: 3209716
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Monoamine oxidase inhibitors. A perspective on their use in the elderly.
    Volz HP; Gleiter CH
    Drugs Aging; 1998 Nov; 13(5):341-55. PubMed ID: 9829163
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antidepressive treatment with monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic events: a retrospective observational cohort study.
    van Haelst IM; van Klei WA; Doodeman HJ; Kalkman CJ; Egberts TC;
    J Clin Psychiatry; 2012 Aug; 73(8):1103-9. PubMed ID: 22938842
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy and Adverse Effects of Tranylcypromine and Tricyclic Antidepressants in the Treatment of Depression: A Systematic Review and Comprehensive Meta-analysis.
    Ulrich S; Ricken R; Buspavanich P; Schlattmann P; Adli M
    J Clin Psychopharmacol; 2020; 40(1):63-74. PubMed ID: 31834088
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease).
    Jenike MA
    Am J Psychiatry; 1985 Jun; 142(6):763-4. PubMed ID: 4003602
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy.
    Zametkin A; Rapoport JL; Murphy DL; Linnoila M; Ismond D
    Arch Gen Psychiatry; 1985 Oct; 42(10):962-6. PubMed ID: 3899047
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Hypertension en orthostatic hypotension during use of monoamine oxidase (MAO) inhibitors].
    Zandee WT; Alsma J; Birkenhäger TK; den Meiracker AHV; van Hoek M; Versmissen J
    Tijdschr Psychiatr; 2017; 59(6):366-371. PubMed ID: 28613369
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study.
    Ludwig VM; Sauer C; Young AH; Rucker J; Bauer M; Findeis H; Ritter P
    CNS Drugs; 2021 Aug; 35(8):881-892. PubMed ID: 34283390
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Do antihypertensives make tranylcypromine safer? Three case reports.
    Taylor BP; Quitkin FM; McGrath PJ; Stewart JW
    J Clin Psychiatry; 2005 May; 66(5):657-8. PubMed ID: 15889959
    [No Abstract]   [Full Text] [Related]  

  • 80. Tranylcypromine versus imipramine in anergic bipolar depression.
    Himmelhoch JM; Thase ME; Mallinger AG; Houck P
    Am J Psychiatry; 1991 Jul; 148(7):910-6. PubMed ID: 2053632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.